Is Lipoprotein(a) a Risk Factor for Blood Clots? Gregory Piazza and Team Publish Landmark Study
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on LinkedIn:
”Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease, including heart attack. Testing for lipoprotein(a) is even a recommendation in some guidelines to identify patients at risk for early heart disease. But is lipoprotein(a) a risk factor for venous thrombosis as well? A recent publication from my group explores the links between lipoprotein(a) and blood clots.”
Read the full article here.
Title: Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Authors: Mariana B Pfeferman, Sina Rashedi, Gregory Y H Lip, Christian Weber, Michelle L O’Donoghue, Steven Nissen, Stephen J Nicholls, Pradeep Natarajan, Jorge Plutzky, Peter Libby, Samuel Z Goldhaber, Gregory Piazza, Behnood Bikdeli
Stay updated with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: A Few Minutes of Giving Can Mean a Lifetime
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion